Related Experiment Video
Updated: Jul 29, 2026

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine
Published on: February 9, 2016
Adenosine is not responsible for local metabolic control of coronary blood flow in dogs during exercise
J D Tune1, K N Richmond, M W Gorman
1Department of Physiology and Biophysics, University of Washington School of Medicine, Seattle, Washington 98195, USA.
Insights
Adenosine does not regulate coronary blood flow during exercise in dogs. This study found no evidence that adenosine plays a role in exercise-induced coronary hyperemia, challenging previous assumptions about local metabolic control.
Area of Science:
- Cardiovascular Physiology
- Exercise Physiology
- Pharmacology
Background:
- Coronary exercise hyperemia is the increase in blood flow to the heart muscle during physical activity.
- Adenosine is a nucleoside that has been implicated as a potential mediator of local metabolic control of coronary blood flow.
- Understanding the precise mechanisms regulating coronary blood flow during exercise is crucial for cardiovascular health.
Purpose of the Study:
- To quantitatively assess the role of adenosine in mediating coronary exercise hyperemia in a canine model.
- To investigate whether adenosine acts as a local metabolic regulator of coronary blood flow during exercise.
Main Methods:
- Dogs were instrumented to measure cardiac hemodynamics and coronary blood flow.
- Cardiac interstitial adenosine concentration was estimated using a mathematical model.
- Adenosine receptor blockade was performed using 8-phenyltheophylline (8-PT) or 8-p-sulfophenyltheophylline (8-PST) during rest and graded treadmill exercise.
Main Results:
- Exercise significantly increased myocardial oxygen consumption and coronary blood flow, but not mean aortic pressure.
- Estimated interstitial adenosine concentration did not rise sufficiently during exercise to suggest a role in vasodilation.
- Adenosine receptor blockade did not affect resting or exercise-induced changes in myocardial oxygen consumption or coronary blood flow.
Conclusions:
- Adenosine is not responsible for the local metabolic control of coronary blood flow in dogs during exercise.
- The findings challenge the hypothesis that adenosine acts as a high-gain, negative-feedback regulator of coronary blood flow during physical exertion.
Abstract:
The purpose of this investigation was to quantitatively evaluate the role of adenosine in coronary exercise hyperemia. Dogs (n = 10) were chronically instrumented with catheters in the aorta and coronary sinus, and a flow probe on the circumflex coronary artery. Cardiac interstitial adenosine concentration was estimated from arterial and coronary venous plasma concentrations using a previously tested mathematical model. Coronary blood flow, myocardial oxygen consumption, heart rate, and aortic pressure were measured at rest and during graded treadmill exercise with and without adenosine receptor blockade with either 8-phenyltheophylline (8-PT) or 8-p-sulfophenyltheophylline (8-PST). In control vehicle dogs, exercise increased myocardial oxygen consumption 4.2-fold, coronary blood flow 3.8-fold, and heart rate 2.5-fold, whereas mean aortic pressure was unchanged. Coronary venous plasma adenosine concentration was little changed with exercise, and the estimated interstitial adenosine concentration remained well below the threshold for coronary vasodilation. Adenosine receptor blockade did not significantly alter myocardial oxygen consumption or coronary blood flow at rest or during exercise. Coronary venous and estimated interstitial adenosine concentration did not increase to overcome the receptor blockade with either 8-PT or 8-PST as would be predicted if adenosine were part of a high-gain, negative-feedback, local metabolic control mechanism. These results demonstrate that adenosine is not responsible for local metabolic control of coronary blood flow in dogs during exercise.
Related Concept Videos
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Pathophysiology of Cardiac Performance
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

